3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
14
Non-Muscle Invasive Bladder Neoplasms
10
Colorectal Neoplasms
7
Appendiceal Neoplasms
6
Anus Neoplasms
6
Peritoneal Neoplasms
5
Carcinoma, Transitional Cell
5
Stomach Neoplasms
2
Pseudomyxoma Peritonei
2
Ovarian Neoplasms
2
Uterine Neoplasms
1
Urothelial Carcinoma of the Bladder
1
Urologic Neoplasms
1
Urologic Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Urinary Bladder Diseases
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Recurrence
1
Rectal Neoplasms
1
Pleural Neoplasms
1
Peritoneal Diseases
1
Neoplasms by Site
1
Neoplasms
1
Neoplasm Metastasis
1
Necrosis
1
Nasopharyngeal Carcinoma
1
Mediastinal Neoplasms
1
Male Urogenital Diseases
1
Interventions
Paclitaxel
40
Carboplatin
34
Bevacizumab
29
liposomal doxorubicin
20
Specimen Handling
18
Taxes
17
olaparib
16
Magnetic Resonance Spectroscopy
16
pembrolizumab
15
Gemcitabine
15
Topotecan
13
Immunoglobulin G
11
Disulfides
11
Biopsy
11
mirvetuximab soravtansine
8
niraparib
7
Nivolumab
7
Doxorubicin
7
Cyclophosphamide
6
Cisplatin
6
Drug Therapy
5
130-nm albumin-bound paclitaxel
5
cemiplimab
4
cediranib
4
Letrozole
4
Injections
4
Docetaxel
4
1-dodecylpyridoxal
4
sarilumab
3
rucaparib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Fallopian Tube Neoplasms
×
Mitomycin
×
1 year
×
Clear all
No trials found.